Ordinary Shares - Class A (CN50) Quote

https://crypto.news/uaes-bitcoin-mining-firm-phoenix-group-expands-in-us-ahead-of-nasdaq-listing-report/

$ILLR How Triller’s NASDAQ Debut May Shake Up Digital Entertainment
https://www.usatoday.com/story/special/contributor-content/2024/12/26/how-trillers-nasdaq-debut-may-shake-up-digital-entertainment/77238585007/

A new contender is poised to make waves in the digital entertainme

Looking good so far 

you forget one word: *multi* - millionaire

https://x.com/THIS_TIME_X/status/1876227247750951247

Did they miss Q4 target? Someone knows. Share price remains under heavy pressure. Also, sneaky ATM cash raise remains an overhang. Common shareholders are the only ones screwed since Lifileucel received accelerated approval in Feb 2024. Post approval it’s down by over 20%. It appears the downtr

PLTR .... Momentum is a powerful force that you should never discount.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175175843

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175178528

I believe the walls will be closing in on him and his daughter, not for pay back
for what he did to Trump, but for how he most likely broke the law, of course
just my opinion

Good morning to stay inside :)

More bullshit.

DRAMA DRAMA DRAMA 

Retail doesn’t even know about this one. The shares are going from one pocket into the other. Once it’s ready, news will come and it will skyrocket possibly over .01.

.002 - .003 Target

So you think that JPM has been owing payments of billions of dollars for more than 16 years (!) - but you have not once spoken to a lawyer or accountant to get to the facts?

JPM doesn’t recognize any such liability, the statute of limitations would have long run out on any claims any

C
Citi upgraded to Overweight from Equal Weight at Barclays
Barclays upgraded Citi to Overweight from Equal Weight with a price target of $95, up from $70. Despite the recent run-up, large-cap banks can continue to outperform the market into 2025 as earnings growth accelerates, the

AMPL
Amplitude upgraded to Overweight from Neutral at Piper Sandler
Piper Sandler upgraded Amplitude to Overweight from Neutral with a price target of $15, up from $11. The company's new leadership additions and acquisitions "could begin to bear fruit in 2025," the analyst tells inv

I would also like to know what is going on behind the scenes and who possibly could know that without Jake telling them... (nothing is happening, the courts in NY are public)

BEST SELLERS RANK (BSR) IS 854 3 Estimated Sold on Amazon Since JAN 1 - 1ST Quarter 2025
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value Decr

AAL
American Airlines upgraded to Buy from Hold at Jefferies
Jefferies upgraded American Airlines to Buy from Hold with a price target of $20, up from $12. The firm's 2025 EPS estimate of $2.55 is 14% above the Street from higher TRASMs, while the industry backdrop supports low-sing

3.60

Good morning

On high alert

Have a great week...eom

Who gets the short end of the stick?
To be left in the lurch.
https://www.youtube.com/watch?v=h1Yjmbc6768

Good morning. Looking good.

$MEGL

Regarding H5N1 as far as i am aware none of the drugs mentioned in the post have been tested against the current version of H5N1. The CDC notes some changes in genetic sequence which may affect the susceptibility of these drugs. Baloxavair is specifically not recommended due to these changes accordi